论文信息 - Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit - 字舞流文

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit

W. Miller | G. Ghanem | A. Awada | F. Journé | A. Najem | F. Sales | Mohammad Krayem | S. D. del Rincón | Malak Sabbah | S. D. Del Rincon | S. D. Del Rincón | Sonia V. del Rincón